Metagenomi Therapeutics (MGX) Current Deferred Revenue (2023 - 2026)
Metagenomi Therapeutics' Current Deferred Revenue came in at $11.2 million for Q2 2026, down 40.9% from $18.94 million a year earlier but up 20.3% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Current Deferred Revenue (2023 - 2026) Analysis & Trends
At the end of FY2025, Metagenomi Therapeutics' Current Deferred Revenue was $8.7 million, down 61.8% from FY2024.
- Going back by year, Current Deferred Revenue was $22.76 million in FY2024 (-52.6%) and $48.07 million in FY2023.
- The five-year range for quarterly Current Deferred Revenue is $8.7 million (Q4 2025) to $48.29 million (Q1 2024).
- Year-over-year, Current Deferred Revenue has declined for seven consecutive quarters, with an average decline of 52.0% over the last seven quarters.
- Business Quant data shows MGX's Current Deferred Revenue at $9.31 million (Q1 2026), $8.7 million (Q4 2025) and $12.9 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Metagenomi Therapeutics | 42.69 Mn | 42.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.20 Mn |
| Mar 31, 2026 | 9.31 Mn |
| Dec 31, 2025 | 8.70 Mn |
| Sep 30, 2025 | 12.90 Mn |
| Jun 30, 2025 | 18.94 Mn |
| Mar 31, 2025 | 25.50 Mn |
| Dec 31, 2024 | 22.76 Mn |
| Sep 30, 2024 | 29.05 Mn |
| Jun 30, 2024 | 32.98 Mn |
| Mar 31, 2024 | 48.29 Mn |
| Dec 31, 2023 | 48.07 Mn |
API Access
Metagenomi Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();